| abstract |
The present invention relates to a C-glucoside derivative containing a fused phenyl ring, a pharmaceutically acceptable salt thereof, a process for preparing the same, a pharmaceutical composition containing the same, a use thereof, and a double suppression method of SGLT1 and SGLT2 using the same. Since the novel compounds of the present invention have double inhibitory activity of SGLT1 and SGLT2, they can be effectively used as a therapeutic agent for diabetes. |